RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,548 | +5.9% | 1,516 | -13.1% | 0.00% | – |
Q2 2023 | $4,293 | +16.4% | 1,745 | +6.9% | 0.00% | – |
Q1 2023 | $3,688 | -82.8% | 1,632 | -73.5% | 0.00% | -100.0% |
Q4 2022 | $21,457 | -26.0% | 6,148 | +458.9% | 0.00% | -33.3% |
Q1 2022 | $29,000 | -14.7% | 1,100 | -27.5% | 0.00% | 0.0% |
Q4 2021 | $34,000 | -61.8% | 1,517 | -55.6% | 0.00% | -57.1% |
Q3 2021 | $89,000 | – | 3,417 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |